OXYTROL FOR WOMEN- oxybutynin patch 
MSD Consumer Care, Inc.

----------

Oxytrol® For Women

Drug Facts

Active ingredient (in each patch [transdermal system])

Oxybutynin 3.9 mg/day

Purpose

Overactive bladder treatment

Use

Warnings

For external use only

Frequent urination can also be caused by:

If you think you might have one of these conditions, it is important to see your doctor before use.

Sleepiness, dizziness, and blurry vision may occur. Do not drive or operate machinery until you know how the patch affects you.

Do not use if you

  • have any of these symptoms, which could be the sign of a UTI or other serious condition.

See your doctor as soon as possible if you have:

 
  • pain or burning when urinating. These symptoms may also be accompanied by a fever or chills
  • blood in your urine
  • unexplained lower back or side pain
  • urine that is cloudy, or foul-smelling
  • are male. Your symptoms may be due to a more serious condition.
  • are under the age of 18. It is not known if it works or is safe in children.
  • only experience accidental urine loss when you cough, sneeze or laugh, you may have stress incontinence. This product will not work for that condition.
  • have been told by a doctor you have urinary retention (are not able to empty your bladder)
  • have been told by a doctor you have gastric retention (your stomach empties slowly after a meal)
  • have glaucoma
  • are allergic to oxybutynin

Ask a doctor before use if you have

  • symptoms of diabetes, such as:
    • excessive thirst
    • extreme hunger
  • unexplained weight loss
  • liver or kidney disease

Ask a doctor or pharmacist before use if you are

  • taking a prescription medication for overactive bladder
  • taking any drugs that may cause sleepiness, dizziness, dry mouth, constipation or blurred vision
  • taking certain antibiotics (for example, erythromycin, clarithromycin) or prescription antifungals (for example ketoconazole, itraconazole)

When using this product

  • you may have itching, rash or redness where the patch was placed
  • drinking alcohol may increase sleepiness

Stop use and ask a doctor if

  • you are not able to empty your bladder (urinary retention)
  • condition worsens, or if new symptoms appear
  • condition does not improve after 2 weeks of use
  • you have an allergic reaction to this product
  • if you have severe redness, itchiness or blistering at the site of application

If pregnant or breastfeeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

women 18 years of age and older

How to use the patch:

How to dispose of a used patch:

Other information

Inactive ingredients

Acrylic adhesive, polyester/ethylene-vinyl acetate film, siliconized polyester film, and triacetin

Question or comments?

Call toll-free 1-888-OXYTROL (1-888-699-8765) between 8:00 AM and 5:00 PM Central Standard Time. Monday through Friday

Distributed by MSD Consumer Care, Inc., PO Box 377, Memphis, TN 38151 USA,
a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ USA.

PRINCIPAL DISPLAY PANEL - 1 Patch Pouch

FOLD AT LINE
TEAR AT ARROW

NDC 11523-4311-1

Full Prescription Strength

OXYBUTYNIN TRANSDERMAL SYSTEM 3.9 mg/day
Overactive Bladder Treatment

Oxytrol®
FOR WOMEN

RELIEF FROM
Overactive Bladder

Product comes in individual sealed pouches, do not use if pouch is torn or opened.
Store between 20° to 25°C (68° to 77°F). Protect from moisture and humidity. Do not store outside the sealed pouch.

1 Patch Treats for
4 Days/4 Nights

Contents:
1
PATCH
(Transdermal System)

PRINCIPAL DISPLAY PANEL - 1 Patch Pouch

PRINCIPAL DISPLAY PANEL - 4 Patch Carton

New!

NDC 11523-4322-4

Full Prescription Strength

OXYBUTYNIN TRANSDERMAL SYSTEM 3.9 mg/day
Overactive Bladder Treatment

Oxytrol®
FOR WOMEN

RELIEF FROM
Overactive Bladder

1 Patch Treats for
4 Days/4 Nights

4
PATCHES
(Transdermal Systems)
16-Day Supply

Principal Display Panel - 4 Patch Carton
OXYTROL FOR WOMEN 
oxybutynin patch
Product Information
Product TypeHUMAN OTC DRUG LABELItem Code (Source)NDC:11523-4311
Route of AdministrationTRANSDERMALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
oxybutynin (oxybutynin) oxybutynin3.9 mg  in 1 d
Inactive Ingredients
Ingredient NameStrength
triacetin 
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11523-4311-11 in 1 POUCH
14 d in 1 PATCH
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA20221108/19/2013
OXYTROL FOR WOMEN 
oxybutynin patch
Product Information
Product TypeHUMAN OTC DRUG LABELItem Code (Source)NDC:11523-4322
Route of AdministrationTRANSDERMALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
oxybutynin (oxybutynin) oxybutynin3.9 mg  in 1 d
Inactive Ingredients
Ingredient NameStrength
triacetin 
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11523-4322-28 in 1 CARTON
14 d in 1 PATCH
2NDC:11523-4322-44 in 1 CARTON
24 d in 1 PATCH
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA20221108/19/2013
Labeler - MSD Consumer Care, Inc. (968091715)

Revised: 8/2013
Document Id: ab8d1f88-4d6e-42d4-b871-171d83f884b5
Set id: 524ee235-0b8a-474f-99ee-f278dbbc5c8e
Version: 1
Effective Time: 20130813
 
MSD Consumer Care, Inc.